Glucocorticoids in acute pancreatitis: a propensity score matching analysis
Abstract Background There are few reports about the effect of glucocorticoids in the treatment of acute pancreatitis in humans. This study aims to evaluate the effect of glucocorticoids in the treatment of acute pancreatitis by propensity score matching analysis. Results Acute pancreatitis patients...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-08-01
|
Series: | BMC Gastroenterology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12876-021-01907-1 |
id |
doaj-a1489c0d026b4c558e254059004a82ad |
---|---|
record_format |
Article |
spelling |
doaj-a1489c0d026b4c558e254059004a82ad2021-08-29T11:19:38ZengBMCBMC Gastroenterology1471-230X2021-08-012111910.1186/s12876-021-01907-1Glucocorticoids in acute pancreatitis: a propensity score matching analysisMeng Wang0Zongxing Jiang1Hongyin Liang2Department of Traditional Chinese Medicine, General Hospital of Western Theater Command (Chengdu Military General Hospital)Department of General Surgery, General Hospital of Western Theater Command (Chengdu Military General Hospital)Department of General Surgery, General Hospital of Western Theater Command (Chengdu Military General Hospital)Abstract Background There are few reports about the effect of glucocorticoids in the treatment of acute pancreatitis in humans. This study aims to evaluate the effect of glucocorticoids in the treatment of acute pancreatitis by propensity score matching analysis. Results Acute pancreatitis patients admitted between 2014 and 2019 were collected from the database and analyzed. Included patients were divided into the glucocorticoids-used group (GC group) and the non-glucocorticoids-used group (NGC group) according to whether glucocorticoids were used. A total of 818 eligible patients were included in the final analysis. Seventy-six patients were treated with glucocorticoids, and 742 patients were treated without glucocorticoids. Before propensity score matching, the triglyceride levels (38.2 ± 18.5 vs. 20.2 ± 16.8, P < 0.05) and Acute Physiology and Chronic Health Evaluation II (APACHE II) scores (7.1 ± 2.5 vs. 4.5 ± 2.1, P < 0.05) at admission were significantly higher in the GC group than in the NGC group. The incidence of multi-organ failure (33.3% vs. 11.9%, P < 0.05) was significantly higher in the GC group than in the NGC group. Patients in the GC group showed a positive balance of fluid intake and output over 72 h. After 1:1 propensity score matching, 59 patients from each group (GC and NGC) were included in the analysis. There were no significant differences in age, sex, body mass index, triglycerides, or APACHE II scores between the two groups (P > 0.05), and the patients’ clinical outcomes were reversed. The proportion of patients with organ failure (40.7% vs. 52.5%, p < 0.05) and multi-organ failure (35.0% vs. 67.7%, P < 0.05) was significantly lower in the GC group than in the NGC group. Furthermore, patients in the GC group had significantly shorter lengths of hospital stay (12.9 ± 5.5 vs. 16.3 ± 7.7, P < 0.05) and costs (25,348.4 ± 2512.6vs. 32,421.7 ± 2813.3, P < 0.05) than those in the NGC group. Conclusions This study presents preliminary confirmation of the beneficial effect of glucocorticoids in the treatment of acute pancreatitis. More high-quality prospective studies are needed in the future.https://doi.org/10.1186/s12876-021-01907-1GlucocorticoidsAcute pancreatitisHypertriglyceridemicPropensity score matching analysis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Meng Wang Zongxing Jiang Hongyin Liang |
spellingShingle |
Meng Wang Zongxing Jiang Hongyin Liang Glucocorticoids in acute pancreatitis: a propensity score matching analysis BMC Gastroenterology Glucocorticoids Acute pancreatitis Hypertriglyceridemic Propensity score matching analysis |
author_facet |
Meng Wang Zongxing Jiang Hongyin Liang |
author_sort |
Meng Wang |
title |
Glucocorticoids in acute pancreatitis: a propensity score matching analysis |
title_short |
Glucocorticoids in acute pancreatitis: a propensity score matching analysis |
title_full |
Glucocorticoids in acute pancreatitis: a propensity score matching analysis |
title_fullStr |
Glucocorticoids in acute pancreatitis: a propensity score matching analysis |
title_full_unstemmed |
Glucocorticoids in acute pancreatitis: a propensity score matching analysis |
title_sort |
glucocorticoids in acute pancreatitis: a propensity score matching analysis |
publisher |
BMC |
series |
BMC Gastroenterology |
issn |
1471-230X |
publishDate |
2021-08-01 |
description |
Abstract Background There are few reports about the effect of glucocorticoids in the treatment of acute pancreatitis in humans. This study aims to evaluate the effect of glucocorticoids in the treatment of acute pancreatitis by propensity score matching analysis. Results Acute pancreatitis patients admitted between 2014 and 2019 were collected from the database and analyzed. Included patients were divided into the glucocorticoids-used group (GC group) and the non-glucocorticoids-used group (NGC group) according to whether glucocorticoids were used. A total of 818 eligible patients were included in the final analysis. Seventy-six patients were treated with glucocorticoids, and 742 patients were treated without glucocorticoids. Before propensity score matching, the triglyceride levels (38.2 ± 18.5 vs. 20.2 ± 16.8, P < 0.05) and Acute Physiology and Chronic Health Evaluation II (APACHE II) scores (7.1 ± 2.5 vs. 4.5 ± 2.1, P < 0.05) at admission were significantly higher in the GC group than in the NGC group. The incidence of multi-organ failure (33.3% vs. 11.9%, P < 0.05) was significantly higher in the GC group than in the NGC group. Patients in the GC group showed a positive balance of fluid intake and output over 72 h. After 1:1 propensity score matching, 59 patients from each group (GC and NGC) were included in the analysis. There were no significant differences in age, sex, body mass index, triglycerides, or APACHE II scores between the two groups (P > 0.05), and the patients’ clinical outcomes were reversed. The proportion of patients with organ failure (40.7% vs. 52.5%, p < 0.05) and multi-organ failure (35.0% vs. 67.7%, P < 0.05) was significantly lower in the GC group than in the NGC group. Furthermore, patients in the GC group had significantly shorter lengths of hospital stay (12.9 ± 5.5 vs. 16.3 ± 7.7, P < 0.05) and costs (25,348.4 ± 2512.6vs. 32,421.7 ± 2813.3, P < 0.05) than those in the NGC group. Conclusions This study presents preliminary confirmation of the beneficial effect of glucocorticoids in the treatment of acute pancreatitis. More high-quality prospective studies are needed in the future. |
topic |
Glucocorticoids Acute pancreatitis Hypertriglyceridemic Propensity score matching analysis |
url |
https://doi.org/10.1186/s12876-021-01907-1 |
work_keys_str_mv |
AT mengwang glucocorticoidsinacutepancreatitisapropensityscorematchinganalysis AT zongxingjiang glucocorticoidsinacutepancreatitisapropensityscorematchinganalysis AT hongyinliang glucocorticoidsinacutepancreatitisapropensityscorematchinganalysis |
_version_ |
1721186956551913472 |